BSE Live
Sep 09, 16:01Prev. Close
1947.10
Open Price
1947.00
Bid Price (Qty.)
1946.05 (30)
Offer Price (Qty.)
1965.00 (29)
NSE Live
Sep 09, 15:59Prev. Close
1947.20
Open Price
1937.10
Bid Price (Qty.)
1957.30 (126)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Lupin (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 15,142.80 | 14,318.05 | 15,559.84 | 17,119.80 | 13,757.87 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 7.60 | 126.95 | 123.93 | |
Revenue From Operations [Net] | 15,142.80 | 14,318.05 | 15,552.24 | 16,992.85 | 13,633.94 | |
Total Operating Revenues | 15,374.76 | 14,664.56 | 15,796.55 | 17,367.38 | 14,131.61 | |
Other Income | 483.76 | 333.01 | 150.35 | 106.51 | 185.19 | |
Total Revenue | 15,858.52 | 14,997.57 | 15,946.90 | 17,473.89 | 14,316.80 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 3,163.82 | 3,145.96 | 2,955.43 | 2,948.66 | 2,758.67 | |
Purchase Of Stock-In Trade | 2,258.23 | 2,004.58 | 2,156.19 | 2,390.65 | 2,019.82 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FGWIP And Stock In Trade | 8.55 | -204.45 | 162.78 | -337.88 | -445.92 | |
Employee Benefit Expenses | 2,986.84 | 2,770.17 | 2,864.71 | 2,849.52 | 2,141.62 | |
Finance Costs | 362.98 | 302.49 | 204.35 | 152.53 | 59.47 | |
Depreciation And Amortisation Expenses | 970.22 | 846.05 | 1,085.87 | 912.23 | 487.13 | |
Other Expenses | 4,602.52 | 4,387.58 | 4,509.93 | 5,023.29 | 3,972.07 | |
Total Expenses | 14,353.16 | 13,252.38 | 13,939.26 | 13,939.00 | 10,992.86 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,505.36 | 1,745.19 | 2,007.64 | 3,534.89 | 3,323.94 | |
Exceptional Items | -752.07 | -339.98 | -1,464.35 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 753.29 | 1,405.21 | 543.29 | 3,534.89 | 3,323.94 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 686.97 | 849.68 | 534.98 | 1,088.21 | 1,143.35 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 470.14 | 38.26 | -246.52 | -109.70 | -84.01 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 1,157.11 | 887.94 | 288.46 | 978.51 | 1,059.34 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | -403.82 | 517.27 | 254.83 | 2,556.38 | 2,264.60 | |
Profit/Loss From Continuing Operations | -403.82 | 517.27 | 254.83 | 2,556.38 | 2,264.60 | |
Profit/Loss For The Period | -273.72 | 611.73 | 254.83 | 2,556.38 | 2,264.60 | |
Minority Interest | 0.39 | -8.93 | -7.09 | -7.17 | -8.76 | |
Consolidated Profit/Loss After MI And Associates | -269.39 | 606.55 | 251.26 | 2,557.46 | 2,260.74 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | -6.00 | 13.00 | 6.00 | 57.00 | 50.00 | |
Diluted EPS (Rs.) | -6.00 | 13.00 | 6.00 | 56.00 | 50.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 226.30 | 226.08 | 338.81 | 338.24 | 337.42 | |
Tax On Dividend | 46.52 | 46.47 | 68.97 | 68.86 | 68.64 |
09.09.2025
09.09.2025
22.08.2025
11.08.2025
Lupin launches Glucagon injection, targets $122 million annual market in US for low blood sugar
15.05.2025
Lupin Standalone March 2025 Net Sales at Rs 4,485.67 crore, up 32.09% Y-o-Y
28.02.2025
Lupin Consolidated December 2024 Net Sales at Rs 5,767.71 crore, up 10.97% Y-o-Y
17.02.2025
Lupin Standalone December 2024 Net Sales at Rs 4,208.00 crore, up 2.24% Y-o-Y
08.11.2024
Lupin Consolidated September 2024 Net Sales at Rs 5,672.73 crore, up 12.59% Y-o-Y